Novartis SA, Switzerland's second- largest drugmaker, said a patient died and another developed a serious infection in tests of its experimental multiple sclerosis treatment FTY720.
Read article at bloomberg.com
Thursday, June 12, 2008
Novartis says experimental multiple sclerosis treatment FTY720 is linked to death and infection
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";